Make the profile of
Stratica Biosciences yours.

Company description

Stratica Biosciences is an AI-powered spatial biology and multiomics company that translates complex biological data into clinical insights. The company serves researchers and collaborators in the life sciences by providing end-to-end analytical solutions that bridge diagnostics and therapeutics, enabling earlier interventions and empowering tailored treatments through data integration across modalities — from H&E imaging to high-plex spatial multiomics.

Stratica envisions a world where every tissue sample becomes a map of meaningful interactions, decoding cellular communication and immune architecture in human disease. Their unified platform is designed to handle datasets of all sizes and complexities, transforming raw spatial multiomics data into actionable, clinically relevant intelligence.

Core Services and Platform Capabilities

• Assay Agnostic Spatial Multiomics Services: Stratica's unified platform processes single-cell spatial data across leading technologies, delivering comprehensive analytics for a broad category of assay types and enabling actionable insights regardless of the upstream data source.
• Scalable End-to-End Analysis: The platform is engineered to transform raw spatial multiomics data into actionable insights, accommodating datasets of all sizes and complexities through a complete analysis pipeline.
• Contextualized Interpretation: Stratica integrates disease and tissue context into cell characterization, providing deeper biological understanding and clinically relevant insights within the critical spatial landscape.

Technology and Focus Areas

• Integration of single-cell and multi-modal data through AI-driven and machine learning frameworks.
• Biomarker discovery leveraging spatial biology and advanced biostatistics and bioinformatics methodologies.
• Development of integrative frameworks to decode cellular communication and immune architecture in human disease.
• Large-scale tissue atlas initiatives supporting translational research.
• AstroSuite, a co-architected analytical framework designed to decode complex tissue systems and accelerate therapeutic discovery.

Leadership

• Kevin Matthew Byrd, DDS, Ph.D. — CEO & Co-Founder: A scientist-entrepreneur with expertise in cancer biology, immunology, and spatial systems medicine. Kevin has led large-scale tissue atlas initiatives and developed integrative frameworks for decoding cellular communication and immune architecture in human disease, bringing deep translational insight to Stratica's mission.
• Jinze Liu, Ph.D. — CTO & Co-Founder: A computational biologist and technology leader with deep expertise in biostatistics, bioinformatics, and AI-driven biomedical data science. Jinze bridges machine learning, spatial biology, and biomarker discovery, and serves as co-architect of AstroSuite, bringing decades of experience in developing advanced analytical frameworks for complex tissue systems.

Stratica Biosciences positions itself as a translational partner for life sciences organizations seeking to unlock the full potential of spatial multiomics data, accelerating the path from biological discovery to clinical intervention.

AI-generated · replace with your own

Software attributed to Stratica Biosciences

• AstroSuiteView

Edit all with premium access